Clinical trials for myasthenia gravis: a historical perspective

被引：4
|
作者：
Kaminski, Henry J. [1 ]
Alnosair, Eman [1 ]
Algahtani, Rami M. [1 ]
机构：
[1] George Washington Univ, GW Med Fac Associates, Dept Neurol, 2150 Penn Ave, Washington, DC 20008 USA
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 2018年 / 1413卷 / 01期
关键词：
myasthenia gravis; clinical trials; mycophenolate; tacrolimus; prednisone; MYCOPHENOLATE-MOFETIL; IMMUNOSUPPRESSIVE DRUGS; THYMECTOMY TRIAL; PLASMA-EXCHANGE; DOUBLE-BLIND; PLASMAPHERESIS; PREDNISONE; THERAPY; IVIG; CORTICOSTEROIDS;
D O I：
10.1111/nyas.13545
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Symposia dedicated to myasthenia gravis and related disorders date back to 1947 and serve as markers of the progress for the field. We provide a brief historical review of therapy development through the lens of the publications that arose from the close to quinquennial meetings that have been supported nearly since their inception by the Myasthenia Gravis Foundation of America and the New York Academy of Sciences. One can appreciate great advances, false starts, and dead ends that are found in all fields of medicine. We tally up the score card for MG and find points scored, but the win is not yet close.
引用
收藏
页码：5 / 10
页数：6
相关论文
共 50 条
  • [31] The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice
    Burns, Ted M.
    MYASTHENIA GRAVIS AND RELATED DISORDERS I, 2012, 1274 : 99 - 106
  • [32] Choosing the "best" animal model for pre-clinical trials of autoimmune myasthenia gravis
    Shelton, G.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S244 - S245
  • [33] Clinical evaluation and management of myasthenia gravis
    Keesey, JC
    MUSCLE & NERVE, 2004, 29 (04) : 484 - 505
  • [34] Clinical characteristics of myasthenia gravis patients
    Schalke, B
    AKTUELLE NEUROLOGIE, 1998, 25 : S28 - S29
  • [35] Clinical meaningfulness and psychometric robustness of the MG Symptoms PRO scales in clinical trials in adults with myasthenia gravis
    Regnault, Antoine
    Habib, Ali A.
    Creel, Kristin
    Kaminski, Henry J.
    Morel, Thomas
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [36] CLINICAL ELECTROPHYSIOLOGY IN MYASTHENIA-GRAVIS
    STALBERG, E
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1980, 43 (07): : 622 - 633
  • [37] THE CLINICAL FEATURES OF THYMOMA WITH MYASTHENIA GRAVIS
    Omasa, Mitsugu
    Yamada, Tetsu
    Sato, Masaaki
    Aoyama, Akihiro
    Sato, Toshihiko
    Chen, Fengshi
    Sonobe, Makoto
    Bando, Toru
    Date, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S419 - S419
  • [38] Clinical heterogeneity of seronegative myasthenia gravis
    Evoli, A
    Batocchi, AP
    LoMonaco, M
    Servidei, S
    Padua, L
    Majolini, L
    Tonali, P
    NEUROMUSCULAR DISORDERS, 1996, 6 (03) : 155 - 161
  • [39] Clinical predictors for the prognosis of myasthenia gravis
    Wang, Lili
    Zhang, Yun
    He, Maolin
    BMC NEUROLOGY, 2017, 17
  • [40] CLINICAL EYELID MYOTONIA IN MYASTHENIA GRAVIS
    Soleymani, Hunter
    Meiling, James
    Wang, Sean Kuei-Hsin
    Penry, Vanessa Baute
    Mehta, Rachana Gandhi
    MUSCLE & NERVE, 2024, 70 (03) : 626 - 626
12345